0001209191-23-037354.txt : 20230615
0001209191-23-037354.hdr.sgml : 20230615
20230615162850
ACCESSION NUMBER: 0001209191-23-037354
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230614
FILED AS OF DATE: 20230615
DATE AS OF CHANGE: 20230615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Siu Christine
CENTRAL INDEX KEY: 0001743029
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40522
FILM NUMBER: 231017743
MAIL ADDRESS:
STREET 1: C/O EIDOS THERAPEUTICS, INC.
STREET 2: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monte Rosa Therapeutics, Inc.
CENTRAL INDEX KEY: 0001826457
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 HARRISON AVENUE
STREET 2: SUITE 900
CITY: BOSTON
STATE: MA
ZIP: 02118
BUSINESS PHONE: 617-949-2643
MAIL ADDRESS:
STREET 1: 321 HARRISON AVENUE
STREET 2: SUITE 900
CITY: BOSTON
STATE: MA
ZIP: 02118
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-14
0
0001826457
Monte Rosa Therapeutics, Inc.
GLUE
0001743029
Siu Christine
MONTE ROSA THERAPEUTICS, INC.
321 HARRISON AVENUE, SUITE 900
BOSTON
MA
02118
1
0
0
0
0
Stock Option (Right to Buy)
6.59
2023-06-14
4
A
0
20500
0.00
A
2033-06-13
Common Stock
20500
20500
D
The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 14, 2024 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time.
/s/ Ajim Tamboli, Attorney-in-Fact
2023-06-15